Work

Refining epidermal growth factor receptor (EGFR) -inhibition-related rash (EIRR) phenotypes with a cetuximab (C) monotherapy stage of a phase II trial for non-small cell lung cancer (NSCLC)

Year: 2008

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2008.26.15_suppl.8089

Authors: M. L. Maitland, K. E. Kasza, M. E. Lacouture, W. Liu, K. Soltani, M. F. Kozloff, P. C. Hoffman, R. Salgia, T. Karrison, E. E. Vokes

Language: English

Topic: Chemotherapy-related skin toxicity

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2591531064

Cites:

Cited by: 2

Related to: 10